Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000298800 | SCV000338396 | benign | not specified | 2016-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000298800 | SCV000517311 | likely benign | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000086062 | SCV001100379 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490748 | SCV002801244 | likely benign | Congenital stationary night blindness 1B | 2022-04-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000086062 | SCV004185324 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | GRM6: BS1, BS2 |
Prevention |
RCV003915113 | SCV004730807 | benign | GRM6-related condition | 2019-05-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Retina International | RCV000086062 | SCV000118206 | not provided | not provided | no assertion provided | not provided |